Innovations and Efficiencies in Oligonucleotide CMC
Exclusive content from TIDES Europe 2024
TIDES Europe 2024 witnessed the largest turnout in the history of the event, welcoming more than 600 attendees from across the globe. The conference took place 30 October – 1 November in Amsterdam, NL and featured new data & case studies from...
Introduction
Advancing oligonucleotide drug delivery through endosomal escape
Oligo Manufacturing Innovations – From Synthesis through Concentration
Process Considerations When Synthesizing Different Oligos
Axolabs NAT: – Initiating CMO Operations at Axolabs Berlin: From Discovery to Commercial Therapeutic Oligonucleotides
Kinds of KANDness: Battling nano-rare disease with oligos
Advancing Oligonucleotide Process Development: Integrating First Principle
Oligonucleotides & Chromatography – What’s New?
Quality Control Strategy of Critical Material of Oligonucleotides (Phosphoramidites)
Amidite RSM Impurity Control and Impact on Oligonucleotide API Quality
Programmable Molecular Technologies for Genome Editing and Cell Control
Exclusive Exhibitor Highlights
TIDES Europe Post-event Report:Innovations and Efficiencies in Oligonucleotide CMC